Induction agent vs paralytic in adult RSI: compare what each drug does, which goes first, and why the timing matters
Published
Induction agent vs paralytic is a question every EMS student asks before their first RSI: in rapid sequence intubation, the induction agent (ketamine, etomidate or propofol) takes away consciousness, and the paralytic, a neuromuscular blocking agent such as rocuronium or succinylcholine, stops muscle movement, breathing included. A paralytic provides no sedation, so the two are always given together. The traditional order is induction agent first, then the paralytic immediately after, though studies have found either order acceptable. Adult patients only: the crew’s protocol and medical direction set the agents, doses and order, not this page. RSI medications for both drug classes lays out all six drugs together.
| Induction agent | Paralytic (NMBA) | |
|---|---|---|
| Job in RSI | Removes consciousness | Stops skeletal muscle movement, breathing included |
| Does not provide | Paralysis (that is the paralytic’s job) | Sedation or pain relief (FDA labels); the patient is not made unaware (StatPearls) |
| On the calculator’s card | Ketamine, etomidate, propofol (“INDUCTION AGENTS”) | Vecuronium, rocuronium, succinylcholine (“NEUROMUSCULAR BLOCKERS”) |
| Onset | Ketamine within 30 seconds; etomidate usually within one minute (FDA labels) | Succinylcholine less than one minute; rocuronium median time to maximum block 1.8 minutes at 0.6 mg/kg, 1.0 minute at 1.2 mg/kg (FDA labels) |
| How long it lasts | Etomidate 3 to 5 minutes; ketamine 5 to 10 minutes (FDA labels) | Succinylcholine about 4 to 6 minutes; rocuronium 31 minutes at 0.6 mg/kg, 67 at 1.2 mg/kg (FDA labels) |
| Traditional order | First (StatPearls) | Immediately after (StatPearls) |
Onset and duration figures are from FDA labels under anesthesia conditions; emergency use may differ. The etomidate and ketamine durations are the labels’ anesthesia durations at 0.3 mg/kg and 2 mg/kg. The rocuronium onset and duration figures are label medians in adults 18 to 64, and its clinical duration ends at 25% twitch recovery, not full recovery; the label’s ranges are 15 to 85 minutes at 0.6 mg/kg and 38 to 160 at 1.2 mg/kg. “On the calculator’s card” describes the app’s screen, not a clinical source, and no app row carries a clinical number. Propofol and vecuronium are on the card but get no onset or duration cells: the table stays to the four drugs the timeline below draws.
Compare the two drug classes: sedative vs paralytic in RSI
One drug takes away consciousness. The other takes away movement. Neither does the other’s job, which is why RSI never gives one alone: “NMBAs must always be used along with an induction (sedating) agent to ensure the patient is unaware of their environment since they will be unable to respond after paralysis,” StatPearls states.
Paralytics split into two families. Succinylcholine is depolarizing: it causes brief muscle fasciculation, then flaccid paralysis. Rocuronium and vecuronium are non-depolarizing: they block the same receptors without first triggering that fasciculation. Rocuronium vs succinylcholine as the paralytic covers which paralytic to reach for.
The calculator’s card lists three induction agents: ketamine, etomidate and propofol. Ketamine vs etomidate as the induction agent covers that choice; this page stays on what each class does and which one goes first.
What is an induction agent for intubation?
A fast-acting IV sedative-hypnotic or dissociative drug, given as a single pre-calculated bolus, that produces unconsciousness for intubation. StatPearls calls etomidate “the most commonly used induction agent for rapid sequence intubation.” The dose itself is a question for the drug-specific pages, not this one.
Can you intubate without a paralytic?
Yes, it happens, but RSI with a paralytic is the described standard. StatPearls calls “rapid sequence intubation using NMBAs” the standard of care, “associated with reduced complications compared to sedatives alone.” Sedation-only or awake techniques are airway management, a different topic than the order of these two drugs, so this page returns to the two-drug sequence: the protocol decides which approach a given patient gets.
Do you give sedative or paralytic first?
The traditional sequence is induction agent first, then the paralytic immediately after. Studies have found either order acceptable, and no guideline settles the question. The protocol governs.
StatPearls describes the traditional step plainly: “Immediately after the induction agent, the paralytic agent of choice is administered intravenously.” The two pushes run back to back, not with a gap between them; the same chapter also describes the step as “the simultaneous administration of the medications for sedation and paralysis.”
Catoire and colleagues (2025) write that “no consensus exists in international guidelines regarding the preferred sequence, leading to considerable variation in clinical practice.” A 2023 review agrees: “insufficient evidence to significantly alter current practices” on order (Engstrom et al., 2023). A 2019 trial analysis concluded: “Administration of either the neuromuscular blocking or the sedative agent first are both acceptable” (Driver et al., 2019).
None of that changes what the calculator does. Its medications card computes both drug classes from one entered weight; it does not pick an order, and neither does this page.
Can rocuronium be administered before etomidate?
Yes. Paralytic-first with rocuronium and etomidate is in documented use, and in a 2025 single-center analysis, paralytic-first was associated with fewer first-attempt failures, not more.
That analysis, by Catoire and colleagues (2025), covered 2,216 analyzed tracheal intubations at a single US emergency department, an urban Level-I adult and pediatric trauma center, January 2021 through January 2024, no lower age limit stated, median age 47. The drugs used were mostly etomidate and rocuronium, and the paralytic went first in 56.6% of cases. First-attempt failure (more than one laryngoscope insertion) was 4.3% paralytic-first versus 5.9% sedative-first, an adjusted odds ratio of 0.73 (95% credible interval 0.46 to 1.02, with a 95.7% probability that the odds ratio was below 1). Hypoxemia showed no difference between orders (OR 0.99, 95% CrI 0.78 to 1.22). Its limits: one center, a credible interval crossing 1, and, as the authors note, no data on awareness during paralysis.
A separate 2019 analysis of an adult ED trial measured something different: of 562 analyzed patients (given both drugs within 30 seconds and intubated on the first attempt), 409 got the paralytic first, and paralytic-first administration was associated with a time from the first drug to the end of the first intubation attempt 6 seconds shorter (95% CI 0 to 11), a surrogate for apnea time (Driver et al., 2019).
Both studies are single-center Hennepin County Medical Center data, both are emergency-department data, and neither is prehospital. Neither result says which order is better or safer for a given patient; the protocol still governs.
Interpret the case for each order: awareness vs apnea time
The argument for each order comes down to which risk it shortens. The case for induction first is avoiding paralysis before the patient is unconscious. The case for paralytic first is shortening the time the patient can’t breathe but isn’t yet paralyzed.
Catoire’s team lays out both sides of the mechanism: sedatives like etomidate and ketamine “have a shorter time to peak clinical effect than most paralytics,” favoring sedative-first “by minimizing the risk of paralysis while the patient is awake.” Paralytic-first instead “may align the peak clinical effects of the sedative and paralytic agents more closely,” possibly shortening the apnea before the patient is paralyzed and ready for laryngoscopy.
Driver and colleagues (2019) frame their own finding as conditional, not a default: paralytic-first “may be a logical default” only “if future research determines that the order of medication administration is not associated with awareness of neuromuscular blockade.” A 2023 review still calls for more awareness research before practice changes (Engstrom et al., 2023), so this page prints no verdict on which risk matters more. The protocol decides.
Recheck the clock: durations don’t match
Whichever order the crew runs, the induction agent wears off in minutes and rocuronium can run half an hour or more. The mismatch opens a window after the tube, well past the push.
By FDA label, etomidate lasts 3 to 5 minutes and ketamine 5 to 10 minutes; succinylcholine lasts about 4 to 6 minutes with a single dose. Rocuronium’s median clinical duration, the label’s time to 25% twitch recovery in adults 18 to 64, is 31 minutes at 0.6 mg/kg and 67 minutes at 1.2 mg/kg, with wide ranges around each; the label has no row at exactly 1 mg/kg, the calculator’s figure, and rocuronium’s RSI dose and how long it lasts covers that gap. Once the tube is placed, StatPearls notes, “appropriate sedation agents should be initiated.”
The ED-AWARENESS study is the field evidence behind that concern: possible or definite awareness with paralysis in 2.6% of mechanically ventilated ED adults (10 of 383), with rocuronium exposure at any point in the ED, during RSI or after the tube, higher among those patients, 70% versus 31.4%, an unadjusted odds ratio of 5.1 (95% CI 1.30 to 20.1). The authors call the result exploratory and hypothesis-generating, note that operating-room studies show longer-acting NMBAs are “an important risk factor” for awareness with paralysis, and did not time awareness against drug wear-off.
Calculate both doses before either push
StatPearls describes RSI doses as “pre-calculated and administered intravenously as a bolus and never titrated.” Rapid Vent Calculator’s medications card computes both drug classes from one entered actual body weight: induction agents under “INDUCTION AGENTS,” paralytics under “NEUROMUSCULAR BLOCKERS,” with the footer “Displayed doses are calculated from entered actual body weight.” The card prints six numbers in two groups. It doesn’t know the blood pressure, the airway plan, the protocol, or the order the crew will push, and it never picks either.
After both drugs: sedation, then the first vent settings
The order question ends when the tube is confirmed. The timing question does not.
Sedation after the tube is scored on a scale rather than eyeballed (NASEMSO v3.0). RASS reads movement, and its validation excluded patients under neuromuscular blockade (Sessler et al., 2002), so a paralyzed patient can’t be scored on it until the block wears off. The RASS scale for the sedation that follows covers that scale, with no band or target here. From there the weight switches too: the card’s doses ran on actual weight, and tidal volume runs on ideal body weight instead (StatPearls NBK537072). Initial vent settings once both drugs are in pick up from there.
Sources
- Hendrix JM, Regunath H. Intubation Endotracheal Tube Medications. In: StatPearls. StatPearls Publishing; updated January 19, 2025. NCBI Bookshelf NBK459276. https://www.ncbi.nlm.nih.gov/books/NBK459276/
- Catoire P, Driver B, Prekker ME, Freund Y. Effect of administration sequence of induction agents on first-attempt failure during emergency intubation: a Bayesian analysis of a prospective cohort. Academic Emergency Medicine. 2025;32(2):123-129. https://pmc.ncbi.nlm.nih.gov/articles/PMC11816003/
- Driver BE, Klein LR, Prekker ME, et al. Drug order in rapid sequence intubation. Academic Emergency Medicine. 2019;26(9):1014-1021. https://pubmed.ncbi.nlm.nih.gov/30834639/
- Engstrom K, Brown CS, Mattson AE, Lyons N, Rech MA. Pharmacotherapy optimization for rapid sequence intubation in the emergency department. American Journal of Emergency Medicine. 2023;70:19-29. https://pubmed.ncbi.nlm.nih.gov/37196592/
- Pappal RD, Roberts BW, Mohr NM, et al. The ED-AWARENESS Study: A Prospective, Observational Cohort Study of Awareness With Paralysis in Mechanically Ventilated Patients Admitted From the Emergency Department. Annals of Emergency Medicine. 2021;77(5):532-544. https://pmc.ncbi.nlm.nih.gov/articles/PMC8166299/
- US Food and Drug Administration. Rocuronium bromide injection prescribing information (Hospira, Inc.). DailyMed; revised June 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=309aeb1b-8022-4df7-8194-ae6529e3395c
- US Food and Drug Administration. Succinylcholine chloride injection prescribing information (Camber Pharmaceuticals / Aspiro Pharma). DailyMed; revised November 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3deac02b-392c-4ee4-9abf-7fe5b8975147
- US Food and Drug Administration. AMIDATE (etomidate) injection prescribing information (Hospira, Inc.). DailyMed; revised April 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7ed5bf8-ba75-44dc-8f81-96b4ad5766be
- US Food and Drug Administration. Ketamine Hydrochloride Injection, USP (CIII) prescribing information (Civica, Inc.). DailyMed; revised June 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58c86d9b-8694-4bd8-8254-f19ee3ad60b0
- NASEMSO Medical Directors Council. National Model EMS Clinical Guidelines, Version 3.0. National Association of State EMS Officials; March 2022.
- Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. American Journal of Respiratory and Critical Care Medicine. 2002;166(10):1338-1344. https://pubmed.ncbi.nlm.nih.gov/12421743/
- Kuhl EA, Perera TB. Prehospital Mechanical Ventilation. In: StatPearls. StatPearls Publishing; updated March 8, 2024. NCBI Bookshelf NBK537072. https://www.ncbi.nlm.nih.gov/books/NBK537072/
